(Q50933649)

English

Role of XRCC3, XRCC1 and XPD single-nucleotide polymorphisms in survival outcomes following adjuvant chemotherapy in early stage breast cancer patients.

scientific article published on 6 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23740134

Role of XRCC3, XRCC1 and XPD single-nucleotide polymorphisms in survival outcomes following adjuvant chemotherapy in early stage breast cancer patients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23740134

single-nucleotide polymorphism

1 reference

based on heuristic

inferred from title

object named as

E Castro

1

0 references

author name string

D Olmos

2

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23740134

A Garcia

3

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23740134

J J Cruz

4

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23740134

R González-Sarmiento

5

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23740134

language of work or name

0 references

publication date

6 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23740134

Clinical and Translational Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23740134

16

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23740134

2

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23740134

158-165

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23740134

https://scigraph.springernature.com/pub.10.1007/s12094-013-1055-8

0 references

Estimates of the cancer incidence and mortality in Europe in 2006.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

Cancer treatment and survivorship statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

Inhibiting effect of the new cytotoxic antibiotic daunomycin on nucleic acids and mitotic activity of HeLa cells

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

Genome maintenance mechanisms for preventing cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

Targeting anthracyclines in early breast cancer: new candidate predictive biomarkers emerge

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

Effect of the anti-neoplastic drug doxorubicin on XPD-mutated DNA repair-deficient human cells

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

DNA repair in response to anthracycline-DNA adducts: a role for both homologous recombination and nucleotide excision repair.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: an appraisal

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

XPD Lys(751)Gln and Asp (312)Asn polymorphisms and bladder cancer risk: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

Cisplatin induces DNA double-strand break formation in Escherichia coli dam mutants.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

DNA repair signature is associated with anthracycline response in triple negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1055-8

21 January 2018

Dependence of nucleic acid degradation on in situ free-radical production by adriamycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/23740134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interstrand DNA crosslinking induced by anthracyclines in tumour cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23740134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

XRCC3 Thr241Met polymorphism with lung cancer and bladder cancer: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23740134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

1 reference

https://pubmed.ncbi.nlm.nih.gov/23740134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23740134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the effects of daunomycin and adriamycin on various DNA polymerases

1 reference

https://pubmed.ncbi.nlm.nih.gov/23740134

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12094-013-1055-8

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23740134

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23740134

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50933649&oldid=1418936218"